Connect with NIDA:

Treatment Research News Releases

Email FacebookTwitter

A whole new view of CB2 (January 25, 2019)
Science Spotlight.
Cascade of Care model recommended for opioid crisis (January 25, 2019)
Science Spotlight.
Study shows impact of social interactions on addictive behavior (October 15, 2018)
Science Spotlight.
2018 Avenir award recipient to study how social networks affect people who use drugs (July 02, 2018)
Announcement.
Training module now available for acute pain management in hospitalized adults (June 27, 2018)
New online course is 10th in a series developed by the NIH Pain Consortium.
Analysis of insurance coverage for back pain shows missed opportunities to prescribe non-opioid medications (June 22, 2018)
Science Spotlight.
Methadone and buprenorphine reduce risk of death after opioid overdose (June 19, 2018)
NIH research confirms effective treatments for opioid use disorder are underutilized.
FDA approves first medication to reduce opioid withdrawal symptoms (May 16, 2018)
Announcement.
Study upends conventional view of opioid mechanism of action (May 10, 2018)
NIH-funded scientists find new molecular target for developing safer pain medications.
Nearly half of opioid-related overdose deaths involve fentanyl (May 01, 2018)
Announcement.
Dr. Kurt Rasmussen to lead NIDA’s therapeutics and medical consequences division (April 30, 2018)
Brings expertise in neuroscience therapeutics.
Study changes long-held concepts of cell decoding (March 28, 2018)
NIH scientists discover macromolecular complexes that could enable medication development.
Non-psychoactive cannabinoid may enable drug addiction recovery (March 26, 2018)
Science Spotlight.
Medication in Prison Associated with Reductions in Fatal Opioid Overdoses After Release (February 14, 2018)
Science Spotlight.
Kappa Opioid Receptor Structure Revealed, A Potential Milestone in Medication Development (January 04, 2018)
Science Spotlight.
Opioid treatment drugs have similar outcomes once patients initiate treatment (November 14, 2017)
NIDA study compares buprenorphine/naloxone combination to extended release naltrexone.
NIDA hosts sessions on pain at APA annual meeting (May 11, 2017)
Media Availability.
Medication plus ongoing care provided in emergency departments is promising approach for opioid dependence (February 23, 2017)
Science Spotlight.
Multi agency funding announcement to assist with opioid crisis in rural U.S. regions (October 07, 2016)
Announcement.
Buprenorphine Prescribers Treat Below Current Patient Limits (September 20, 2016)
Science Spotlight.
Recruitment begins for landmark study of adolescent brain development (September 13, 2016)
More than 10,000 children will participate in study of brain, social, emotional, and cognitive development.
Brain region may manage reward expectations and responding (August 17, 2016)
Science Spotlight.
Smoking cessation success linked to sex difference (July 11, 2016)
Science Spotlight.
Co-prescribing naloxone in primary care settings may reduce ER visits (June 28, 2016)
Science Spotlight.
Addiction treatment patients trained to manage their healthcare may have better outcomes (June 22, 2016)
Science Spotlight.
Pioneering early stage researchers selected for NIDA’s 2016 Avenir awards (June 09, 2016)
Awards recognize cutting edge HIV/AIDS and epigenetics research.
NIDA creates online resource to raise awareness about naloxone (June 02, 2016)
Announcement.
FDA approves six month implant for treatment of opioid dependence (May 26, 2016)
Announcement.
Advancing psychiatric practice through the science of addiction (May 05, 2016)
Media Availability.
Extended-release naltrexone lowers relapse rates in ex-offenders (March 31, 2016)
Science Spotlight.

Pages

Resources for the Media

Featured Publication

NIDA Media Guide

Connecting the scientific community and the media